Search Results for: plus products

Owns patented Invisicare® polymer delivery system, prescription and over-the-counter skincare products formulated with Invisicare Business model to grow globally by out-licensing its proprietary and patented product line Developed multiple cannabis-based products with CBD from imported hemp (non-psychoactive), and will continue to develop line utilizing CBD and THC from marijuana Skinvisible, Inc. (OTCQB: SKVI) is targeting … Continue reading “Skinvisible, Inc. (SKVI) Targets Global Skincare Market Projected to Reach $135B by 2021”

CBD market estimated to grow by 700% by 2020 POTN has scientific focus on quality and therapeutic consistency POTN multiple product lines and global distribution Positioned for outsized share of the growth It’s no wonder that medicinal marijuana, cannabis and hemp (cannabidiol) has become a veritable gold rush given the 700% market upsurge projected over … Continue reading “PotNetwork Holding Inc. (POTN) in the Midst of a 700% Upsurge Market”

Unclear whether amendment will survive in final appropriations bill, but Congressional vote sends message to Attorney General Jeff Sessions CIIX is expanding in global market with online cannabidiol store in Shanghai, China, and brick-and-mortar unit to open in San Gabriel, California Consilium Global Research estimates that CIIX will outperform cannabis market to achieve revenues of … Continue reading “ChineseInvestors.com, Inc. (CIIX) Seen Benefitting from Senate Committee Vote for Amendment Protecting Legal Cannabis”

CannabisNewsWire Editorial Coverage: The backbone of medical advancement is biotechnology, an industry wrought with the incredible potential of novel drug R&D, but vulnerable to the risk of stringent regulatory approval processes. Within this volatile market, however, is the cannabis-biotech sub-sector – a market flourishing with opportunity, innovation, and deep roots of medical possibilities. Fueled by … Continue reading “Biotech Players Lead the Growth Charge in the Legal Cannabis Market”

CannabisNewsWire Editorial Coverage: Mounting research from around the world suggests marijuana’s potential to treat multiple medical conditions ranging from chronic pain to cancer, epilepsy, HIV/AIDS, anxiety and more.  Predicted to reach $55.8 billion by 2025(1), the global medical marijuana industry presents to investors a wide array of investment opportunities, driven by increasing demand for therapeutic … Continue reading “Investment Options in the Multi-Billion Dollar Medical Marijuana Industry”

CannabisNewsWire Editorial Coverage: The legal marijuana market continues to gain momentum, driven by increasing public acceptance and an increasing number of investors looking for viable opportunities on a crowded playing field. According to a recent Gallup poll1, 60 percent of Americans now support the legalization of marijuana. As the playing field continues to grow in … Continue reading “5 Standout Legal Cannabis Companies Worthy of Consideration”

The cannabis plant is comprised of, among other things, phytochemicals that have evolved over time to become very biologically active. Most of the current research and development (R&D) surrounding cannabis revolves around understanding these biologically-active ingredients, especially cannabinoids. To date, over 90 cannabinoids have been isolated from cannabis, each affecting the body’s cannabinoid receptors and … Continue reading “The Value Drivers of InMed Pharmaceuticals, Inc. (IMLFF)”

As the medical marijuana market continues to grow, so does the number of biotech companies expanding their research into the development of innovative cannabinoid-based pharmaceuticals and delivery systems. It is estimated that the U.S. consumer market for cannabinoid pharmaceuticals will increase exponentially in upcoming years, exceeding $50 billion by 2029, according to Statista. This doesn’t … Continue reading “Biotech Innovations Drive Cannabinoid-Based Pharmaceutical Market Growth”